Early detection of colon cancer and advanced polyps
Part of Cancer, Digestive system clinical trials.
This study aims to find colorectal cancer and advanced polyps (adenomas) earlier by looking at blood samples. Researchers hope a simple blood test might one day help detect colon cancer before it spreads.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a colonoscopy (a test where a doctor looks at your colon with a thin tube).
- A blood sample must have been taken before you started any treatment meant to cure the cancer.
- Your diagnosis must be based on standard tests like a colonoscopy and tissue sample (biopsy).
- You cannot have a hereditary colorectal cancer syndrome (a genetic condition that runs in families).
- You cannot have inflammatory bowel disease (like Crohn's disease or ulcerative colitis).
- You must be willing to sign an informed consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve detection of colorectal cancer in people diagnosed before age 50. It compares samples from patients with cancer to those without to find new early detection methods.
This study is looking for people newly diagnosed with colorectal cancer or advanced adenoma to help find better ways to detect the disease early using advanced lab tests on blood samples.
This study uses a simple blood test to find early signs of colorectal cancer in people who already had a positive stool test. If it works, it could help avoid unnecessary colonoscopies in the future.
This study uses a simple blood test (liquid biopsy) and computer analysis to find early signs of colorectal cancer, precancerous growths, and Lynch syndrome. It aims to improve early detection and monitor for any remaining cancer after treatment.
This trial studies a blood test to find early bowel (colon) tumors. It may help detect cancer earlier and avoid more invasive procedures.
This study measures “minimal residual disease,” meaning tiny amounts of cancer that may remain after surgery, using blood samples. It may help doctors better detect who is at higher risk of cancer coming back and guide follow-up care.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.